CD274 and non-small cell lung carcinoma: Consequently, we conducted the first flow cytometry‐based assay31 using a drug array with about two hundred agents to recognize novel inhibitors that could suppress both the radiation‐induced and the cisplatin‐induced cell surface PD‐L1 expression in NSCLC.